Rigel Pharmaceuticals Inc (RIGL)
Income Tax Expense
-$236.33M
TTM · Period ending: · USD
RIGL Income Tax Expense
Latest reported-$236.33Mperiod ending
Latest reported-$236.33Mperiod ending
RIGL TTM Income Tax ($0.00 → -$236.33M)
TTM income tax expense
High-resolution chart · PNG
RIGL income tax expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Income Tax Expense (USD) |
|---|---|
| -236,333,000 | |
| -242,259,000 | |
| -245,197,000 | |
| 1,035,000 | |
| 1,315,000 | |
| 946,000 | |
| 881,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -60,000 | |
| -196,000 | |
| -1,166,000 | |
| 605,000 | |
| 665,000 | |
| 801,000 | |
| 1,771,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -159,000 | |
| -159,000 | |
| -159,000 | |
| -272,000 | |
| -113,000 | |
| -113,000 | |
| -113,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -73,368,000 | |
| -73,368,000 | |
| -73,368,000 | |
| -73,368,000 | |
| -42,255,000 | |
| -42,141,000 | |
| -42,141,000 | |
| -42,141,000 | |
| 204,000 | |
| -237,000 | |
| -161,000 | |
| -114,000 | |
| -111,000 | |
| 216,000 | |
| 113,000 | |
| 0 | |
| -4,461,000 | |
| -4,461,000 | |
| -4,434,000 | |
| -4,368,000 | |
| -55,270,000 | |
| -55,270,000 | |
| -55,270,000 | |
| -55,270,000 | |
| -22,181,000 | |
| -22,181,000 | |
| -22,181,000 | |
| -22,181,000 | |
| -36,363,000 | |
| -36,363,000 | |
| -36,363,000 | |
| -36,363,000 | |
| -612,000 | |
| -612,000 | |
| -612,000 | |
| -612,000 | |
| -29,335,000 | |
| -29,335,000 | |
| -29,335,000 | |
| -29,335,000 | |
| -28,960,000 | |
| -28,960,000 | |
| -28,960,000 | |
| -28,960,000 | |
| -17,694,000 | |
| -17,694,000 | |
| -17,694,000 | |
| -17,694,000 | |
| -19,593,000 |